Regulated Information

In accordance with French legislation, these pages provide access to all regulated information published by Sartorius Stedim Biotech as defined by the French Market Authority (AMF, Autorités des Marchés Financiers).

Furthermore, the Related-party agreements entered into by Sartorius Stedim Biotech are presented below pursuant to Article L. 225-40-2 of the French Commercial Code. 

Downloads

Universal Registration Document | Reference Document

Reports since 2009

Half-Year Reports

Reports since 2009

Quarterly Reports

Reports since 2009

Voting Rights & Shares

Voting rights and share making up the issued capital

Reports on Liquidity Contracts 

Share Buybacks

Managers‘ Transactions

2024

2022

2020

2019

2018

2017

Financial Publications 

Learn More